介质细胞干细胞/流体细胞作为败血症的治疗方法:对我们目前的状况的回顾?

Courtney Premer1, Joshua M Hare2, Sarah Y Yuan3

  • 1Department of Emergency Medicine, McGaw Medical Center of Northwestern University, 211 E Ontario Street, Suite 200, Chicago, IL, 60611, USA. Courtney.premer-barragan@northwestern.edu.

PubMed
概括

由于其抗炎性质,介质干细胞/介质干细胞 (MSCs) 显示出对败血症治疗的前景. 虽然在试验中是安全的,但需要进一步的研究来优化MSC治疗败血症患者.